DOD Mefloquine Policy Mirrors FDA Update on Malaria Drug
Military Health System sent this bulletin at 09/26/2013 03:42 PM EDTHaving trouble viewing this email? View it as a Web page.
You are subscribed to no topic for Military Health System.
09/26/2013 02:37 PM EDT
The Defense Department’s policy on the antimalarial drug mefloquine, which has been in use for decades, is consistent with a stronger, updated warning about the drug from the Food and Drug Administration, senior DOD officials said.
 |
Questions for MHS? Contact Us |
| STAY CONNECTED: | ||||
 |
 |
 |
 |
 |
| SUBSCRIBER SERVICES: | ||||||
| Manage Preferences | | | Delete profile | | | Help | |
|